Skip to content

Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus

Myocardial Dysfunction in Pediatric Lupus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07425730
Enrollment
60
Registered
2026-02-23
Start date
2026-02-01
Completion date
2026-07-01
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Lupus Erythematosus (SLE)

Keywords

lupus, echocardiography

Brief summary

To investigate biomarkers to identify pediatric SR-SLE patients by non-invasive echocardiographic techniques.

Detailed description

Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease. Although therapeutic advances have improved outcomes, a significant subset remains with severe disease activity despite optimal therapy, which is recognized as the severe refractory SLE (SR-SLE).A recent study using advanced echocardiographic techniques of global longitudinal strain (GLS) have revealed that left ventricular dysfunction is common in SLE patients and correlates with disease severity.The finding underscores the potential role of early myocardial dysfunction as a phenotypic marker of SR-SLE.To our knowledge, there are no validated biomarkers to reliably identify patients with SR-SLE at an early stage, especially in the pediatric population. Therefore, this study aimed to investigate biomarkers to identify pediatric SR-SLE patients.

Interventions

None listed

Sponsors

Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* fulfill the American College of Rheumatology (ACR) criteria * disease onset at ages before 18 years

Exclusion criteria

* patients with a history of concomitant malignancy * patients with active bacterial, viral, fungal, mycobacterial infection

Design outcomes

Primary

MeasureTime frameDescription
echocardiographic measurements6 monthsechocardiographic measurements including chamber dimensions, LV systolic and diastolic function, valve disease, strain values and etc..

Countries

China

Contacts

PRINCIPAL_INVESTIGATORBao

Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026